Trial intelligence / Profile preview

Bioequivalence Study of Etoricoxib Tablets under Fasting Condition

TCTR20161102001Phase 1Not yet recruiting

Sponsor
Ranbaxy Laboratories
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of etoricoxib (2 arms), sponsored by Ranbaxy Laboratories. Planned start Jan 2017; status: not yet recruiting.

02

Drugs

etoricoxib

Beyond the preview

Go deeper on TCTR20161102001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161102001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call